Paper37559639
Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study.
Satjawattanavimol S and 3 others. J Thorac Dis, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study. Papers, record 37559639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37559639
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence of early bacterial co-infection in hospitalized patients with COVID-19 pneumonia: a retrospective study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32820807 | Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32820807 | PubMed |
| 2 | 35025929 | Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study. | PLoS One | 2022 | https://conductscience.org/library/papers/35025929 | PubMed |
| 3 | 33185241 | An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33185241 | PubMed |
| 4 | 33818909 | Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study. | Clin Respir J | 2021 | https://conductscience.org/library/papers/33818909 | PubMed |
| 5 | 20014950 | Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. | Clin Infect Dis | 2010 | https://conductscience.org/library/papers/20014950 | PubMed |
| 6 | 28864644 | Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. | J Rheumatol | 2017 | https://conductscience.org/library/papers/28864644 | PubMed |
| 7 | 32311650 | Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. | J Clin Virol | 2020 | https://conductscience.org/library/papers/32311650 | PubMed |
| 8 | 32588812 | Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/32588812 | PubMed |
| 9 | 32717489 | Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit. | J Glob Antimicrob Resist | 2020 | https://conductscience.org/library/papers/32717489 | PubMed |
| 10 | 34506514 | Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients. | PLoS One | 2021 | https://conductscience.org/library/papers/34506514 | PubMed |
| 11 | 32745596 | Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/32745596 | PubMed |
| 12 | 32358954 | Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32358954 | PubMed |
| 13 | 35100984 | Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/35100984 | PubMed |
| 14 | 33447639 | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/33447639 | PubMed |
| 15 | 32894364 | Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32894364 | PubMed |
| 16 | 33418017 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/33418017 | PubMed |
| 17 | 33819304 | Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study. | PLoS One | 2021 | https://conductscience.org/library/papers/33819304 | PubMed |
| 18 | 21369807 | Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. | Intensive Care Med | 2011 | https://conductscience.org/library/papers/21369807 | PubMed |
| 19 | 32216717 | Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. | Radiology | 2020 | https://conductscience.org/library/papers/32216717 | PubMed |
| 20 | 32835331 | Low rate of bacterial co-infection in patients with COVID-19. | Lancet Microbe | 2020 | https://conductscience.org/library/papers/32835331 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41640416 | The COVID-19 pandemic: an underlying factor for increased Stenotrophomonas maltophilia infections-A literature review and case study analysis. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41640416 | PubMed |
| 40416960 | The subsets of blood circulating T-cells associated with the development and prognosis of coinfection in patients with critical COVID-19. | Front Immunol | 2025 | https://conductscience.org/library/papers/40416960 | PubMed |
| 40315054 | Activation of the endoplasmic reticulum stress regulator IRE1α compromises pulmonary host defenses. | Cell Rep | 2025 | https://conductscience.org/library/papers/40315054 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37559639
GET https://conductscience.org/api/papers/v1/37559639/references?page=2